Design Therapeutics
Develops GeneTAC small molecules that tune disease-causing gene expression.
$15.11
After-hours close+0.01 (+0.07%)
At close$15.10(−0.98%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.38 | — | — |
| Aug 2026 | −$0.34 | −$0.32 | +7.1% |
| Apr 2026 | −$0.36 | −$0.29 | +19.4% |
| Mar 2026 | −$0.38 | −$0.27 | +28.9% |
| Nov 2025 | −$0.34 | −$0.30 | +11.8% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.38 | — | — | — | — | — |
| Aug 3, 2026 | −$0.34 | −$0.32 | +7.1% | — | — | — |
| Apr 28, 2026 | −$0.36 | −$0.29 | +19.4% | — | — | — |
| Mar 9, 2026 | −$0.38 | −$0.27 | +28.9% | — | — | — |
| Nov 5, 2025 | −$0.34 | −$0.30 | +11.8% | — | — | — |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 7, 2025 | ||||||
| Mar 10, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 5, 2024 | ||||||
| May 8, 2024 | ||||||
| Mar 19, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 9, 2023 | ||||||
| Mar 14, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 9, 2022 | ||||||
| Mar 10, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 10, 2021 | ||||||
| Mar 25, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||